Business Intelligence

An integrated delivery network that covers five and a half million lives is bringing in Google Cloud to help build and maintain a patient-centric platform with advanced analytic and AI capabilities.

An Israeli healthcare AI startup has earned a seventh green light from the FDA. Its latest algorithm can reconstruct X-rays of bones into 3D printouts with no less clarity than would be produced by advanced imaging modalities.

Amazon Web Services is marketing the line to healthcare organizations that are awash in data but lack an efficient way to wring meaning from it.

An Ohio-based healthcare AI company focused on improving fiscal performance for payers as well as providers is buying a like-minded entity with expertise in streamlining prior-authorization processes.  

A women’s health technology company has received the FDA’s blessing to market deep learning-based software designed to help breast radiologists spot hard-to-find nascent cancers in 3D mammograms.

Both outcomes and costs may vary widely from one patient to the next even in hospitals with consistently strong quality scores. Machine learning can help optimize the selection process for each patient as an individual.

The healthcare AI startup founded by developers of the Apple Watch has been greenlit to market an AI-powered mobile application that lets radiologists interpret images and share the results with patients in real time.

AI will only succeed in healthcare to the extent that it wins over all three stakeholder subpopulations—providers, payers and patients.

A new company called DeliverHealth Solutions is forming to service clients of Nuance’s HIM transcription and EHR go-live businesses.

Nonprofit competition organizer XPrize is partnering with global tech consultancy Cognizant to award AI innovators in a pandemic response challenge.

The medical device giant has purchased a French spinal surgery company that currently has more than 30 digital medicine products on the market in the U.S. and Europe.

The COVID crisis will spur leaders of life sciences companies around the world to focus on longstanding pain points that AI could help alleviate. And the execs are looking to put their money where their responses are.